In 1997, the country faced a severe financial crisis; many companies suffered to the extent that some did not survive the economic breakdown.
However, despite the difficult season, Emerging Venture Sdn. Bhd. (now Emerging Pharma) came to birth and persevered through the challenges, focusing strongly in sales activities.
During the stage of our emergence into the industry, we partnered with our following principals to market their products in our territory:
- 1997 - IPSEN, France
Products: - Tanakan®
- Dysport®
- Forlax®
- Fortrans®
- Ginkor Fort®
- Smecta®
- Diphereline®
- 2000 - Alfawassermann, Italy
Products: - Vessel Due F®
- 2002 - Zambon, Italy
Products: - Fluimucil A®
- Monurol®
- Spedifen®
- Hidonac®
- 2003 - Vitrolife, Sweden
Products: - Vitrolife IVF Media®
At the same time, we had successfully liaised with a local distributor to distribute our products to the market.
»Next